Skip to Content

Research in Bone Disease

The Rolanette and Berdon Lawrence Bone Disease Program of Texas, a collaborative research, clinical and education program of Baylor College of Medicine and The University of Texas MD Anderson Cancer Center, was established in 2002 to capitalize on the strengths of these two institutions. The Rolanette and Berdon Lawrence Bone Disease Program of Texas seeks to improve basic and translational research of bone diseases and to convert basic science findings to more effective treatment and prevention options.

Work performed in the laboratories of members of The Rolanette and Berdon Lawrence Bone Disease Program of Texas is defining important steps in the regulation of bone formation and resorption. Bone Program participants are leading the way in identifying transcription factors, developing pharmacologic agents, and studying the role of collagen, the hormone calcitonin and vitamin D analogs in osteoporosis, bone metastasis, osteogenesis imperfecta and other bone disorders.

Participating Laboratories

MD Anderson Cancer Center:

Baylor College of Medicine:


© 2014 The University of Texas MD Anderson Cancer Center